Comprehensive Analysis of the Transfection Reagents And Equipment Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the transfection reagents and equipment market?
In recent times, there has been a significant increase in the size of the transfection reagents and equipment market. The market is projected to expand from its $1.58 billion valuation in 2024 to $1.75 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this considerable growth during the historical period include the surge in demand for biomedical research, developments in pharmaceuticals, increase in biotechnology applications, academic and research institutions’ endeavours, and advancements in genetic engineering.
What will be the transfection reagents and equipment market size in the future?
The market size of transfection reagents and equipment is forecasted to undergo substantial expansion in the upcoming years, with an expectation to reach “$2.69 billion in 2029. The compound annual growth rate is set at 11.3%. This increase in the projection period is linked to advancements in gene therapy, the surge in bioproduction necessities, the emergence of cell-based therapies, innovation in personalized medicine, and global partnerships. The significant trends during this period include a focus on primary cell transfection, moving toward electroporation techniques, incorporating nanotechnology in transfection, growing demand for animal-free transfection reagents, along with the automation and high-throughput transfection systems.
Get your transfection reagents and equipment market report here!
What main drivers are fueling expansion in the transfection reagents and equipment market?
The uptick in cancer patients globally is predicted to stimulate the expansion of the transfection reagents and equipment market. Cancer refers to a set of diseases characterized by abnormal and uncontrolled cell growth. Transfection reagents play a vital role in cancer research, as they aid in the introduction of foreign genetic materials, including plasmid DNA or RNA molecules, allowing researchers to delve deep into various cancer biology aspects such as gene expression studies, gene silencing, drug screening, and target validation. For example, the American Cancer Society, a non-profit organization based in the US, reported 20 million fresh cases of cancer and about 9.7 million deaths in 2022. Consequently, the augmenting number of cancer patients globally fuels the transfection reagents and equipment market’s growth.
What key areas define the segmentation of the global transfection reagents and equipment market?
The transfection reagents and equipment market covered in this report is segmented –
1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems, Other Instruments
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits, Other Reagents And Kits
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp
Who are the dominant players expanding their reach in the transfection reagents and equipment market?
Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH
How are evolving market trends shaping transfection reagents and equipment Strategies?
Trend 1: A dominant trend in the transfection reagents and equipment market currently is product creation with a novel twist. Firms majorly involved in this market are focusing their efforts on introducing unique products to maintain their market stance. For instance, in September 2022, Polyplus-Transfection SA, a biotechnology firm based in France, introduced its in vivo-jetRNA+ transfection reagent for in vivo mRNA delivery utilizing preformed liposome formulation. This notable product acts as an efficient and scalable system for gene delivery, capable of delivering mRNA to a range of tissues and cell types. With safety and good tolerance, it stands out as a strong contender for paving the way for new gene therapies. Its ready-to-use construction eliminates the necessity for formulation phases while maintaining a steady liposome size, allowing for a variety of mRNA concentrations over time, ranging from low to high. Potential applications include prophylactic vaccinations, mRNA treatments such as cancer therapy and rare diseases, and gene editing.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10780
Which regions are emerging as leaders in the transfection reagents and equipment market?
North America was the largest region in the transfection reagents and equipment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Chemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Geocells Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/geocells-global-market-report
Electronic Wet Chemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electronic-wet-chemicals-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
